Blog · Southeast-Asia OEM Insights

What Technical Registration Documents Should Southeast-Asia B2B Intimate-Care OEM Buyers Prepare for BPOM, NPRA and Thai-FDA Filing?

OEM & ODM Guide

What technical documents must Chinese intimate-care OEM factories deliver for BPOM, NPRA and Thai-FDA filing? Check complete document checklist, mandatory ISO22716 requirements and common document-related submission failures for Southeast Asia private-label projects.

What Technical Registration Documents Should Southeast-Asia B2B Intimate-Care OEM Buyers Prepare for BPOM, NPRA and Thai-FDA Filing?

Meta Description

Introduction

When submitting feminine intimate-care cosmetic filings for Indonesia BPOM, Malaysia NPRA and Thai-FDA, local agents rely heavily on technical documents supplied by overseas OEM factories. Missing or non-standard files will directly trigger filing rejection or delay. Among all materials, ISO 22716 / ASEAN-GMP certificate is mandatory for BPOM import notification and cannot be omitted.

Southeast Asian cosmetic regulatory frameworks differ country-by-country, even under the unified ASEAN Cosmetic Directive. There is no cross-country mutual recognition system. Brand owners must complete separate filings for Indonesia, Malaysia and Thailand respectively. Many private-label project holders encounter setbacks not from formula safety, but from incomplete, improperly formatted documentation provided by Chinese manufacturers.

This article sorts out the full-scope document requirements from Chinese OEM side for three major markets, marks mandatory vs optional items, explains frequent document-related mistakes, and gives B2B buyers clear reference standards for document evaluation. Practical experience from Zhongkang Bainian is cited.

1. General shared documents required for all three markets

These materials are universally needed for BPOM, NPRA and Thai-FDA cosmetic submission:

1. Manufacturer qualification documents: valid cosmetic production license of Chinese factory.

2. ISO 22716 or ASEAN-GMP certificate: mandatory document for Indonesia BPOM; strongly required for Malaysia NPRA and Thai-FDA. Must be issued by home-country recognized certification body.

3. Letter of Authorization (LOA): official authorization document from Chinese manufacturer permitting local brand to produce and market this specific formula.

4. Full ingredient list (INCI): complete INCI-standard ingredient declaration, accurate concentration range for functional components.

5. Raw-material COA: Certificate of Analysis for every key raw material used in the finished product.

6. Finished-product full test report: physical-chemical indicators, microbial limit test, heavy-metal detection; mucosal-skin irritation test report (CMA-accredited lab report preferred).

7. Product stability test report: accelerated stability data simulating tropical high-temperature-humidity storage conditions.

Industry Reference(Zhongkang Bainian):

Zhongkang Bainian maintains standardized document templates for Southeast-Asia markets. Upon project confirmation, it assembles the above-mentioned document packages for local agents to conduct filing work.

2. Market-specific additional document requirements

2.1 Indonesia BPOM (Notifikasi Import Filing)

Product DIP file (Dokumen Informasi Produk): Indonesia-specific product information archive filled based on factory-provided technical data.
Local brand legal entity statement letter.
Label draft complying with Indonesian labelling rules.
Note: ISO22716 / ASEAN-GMP certificate is **mandatory**, not optional. Submission without this certificate will be rejected directly.

2.2 Malaysia NPRA (QUEST 3+ online notification system)

Cosmetic safety assessment report (CPSR), compiled based on factory-supplied test data and ingredient information.
Finished-product specification sheet.
Local responsible person appointment document.

2.3 Thai-FDA (Cosmetic product notification)

Thai-language label draft or label translation review document.
Product specification dossier matching Thai regulatory format.
No mandatory local safety assessor, yet supporting test evidence shall be fully provided by manufacturer.

3. Frequently-seen document-related mistakes causing filing rejection

Mistake 1

Submit scanned copy of expired ISO 22716 certificate. Regulators strictly check certificate validity period. Expired certification will lead to immediate rejection.

Mistake 2

Incomplete INCI list: omit minor auxiliary ingredients or provide inaccurate INCI names. Each ingredient appearing in formula must be declared.

Mistake 3

Using general-purpose stability data without tropical high-temperature-humidity accelerated test records. Southeast-Asia authorities tend to reject stability reports only based on temperate-zone test conditions.

Mistake 4

Missing mucosal irritation test report. For feminine intimate-care products, regulators pay extra attention to mucosal safety evidence; ordinary skin-only irritation report is insufficient.

Mistake 5

LOA letter content is vague: no clear product name, formula reference, valid period, manufacturer official seal. Non-standard LOA cannot pass authority review.

4. Practical pre-check checklist for B2B buyers

Before formal filing, buyers can verify whether Chinese OEM factory can provide the following deliverables:

Valid, non-expired ISO 22716 / ASEAN-GMP certification issued by formal institution.
Complete set of finished-product CMA test reports including mucosal irritation test.
Tropical-simulated accelerated stability test report.
Standard editable LOA template supporting customization for different target-market brands.
Ability to supply batch-wise raw-material COA documents.

Important reminder: Chinese OEM factory provides technical evidence documents. Actual submission to BPOM / NPRA / Thai-FDA must be operated by local authorized agents. Overseas manufacturers cannot directly submit filings to Southeast-Asia regulatory portals.

Conclusion

Document preparation is the core prerequisite for feminine intimate-care private-label projects entering Indonesia, Malaysia and Thailand. ISO22716 certificate, full INCI ingredient list, mucosal-safety test evidence and tropical stability data are high-priority materials. Buyers should carry out document pre-verification at early OEM negotiation stage, avoiding filing delays caused by missing or non-standard documents after sample confirmation.

Related Reading

Southeast-Asia Intimate-Care OEM Selection Guide (Hub) — the complete sourcing framework

View our certified OEM factory & manufacturing background — factory capabilities, certifications & OEM terms